Role of cephalosporinase in carbapenem resistance of clinical isolates of Pseudomonas aeruginosa.
AUTOR(ES)
Zhou, X Y
RESUMO
With numerous imipenem-resistant clinical isolates of Pseudomonas aeruginosa as well as in vitro-selected resistant mutants, we have demonstrated, by a simple method with a powerful cephalosporinase inhibitor, BRL42715, the contribution of chromosomal cephalosporinase in resistance to imipenem in this species.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=187975Documentos Relacionados
- Carbapenem Resistance Mechanisms in Pseudomonas aeruginosa Clinical Isolates
- Exotoxin production by clinical isolates of pseudomonas aeruginosa.
- Characterization of elastase-deficient clinical isolates of Pseudomonas aeruginosa.
- Mutational and acquired carbapenem resistance mechanisms in multidrug resistant Pseudomonas aeruginosa clinical isolates from Recife, Brazil
- Production of exoenzyme S by clinical isolates of Pseudomonas aeruginosa.
